An insight into endophytic antimicrobial compounds: an updated analysis.

IF 1.7 4区生物学 Q4 BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Plant Biotechnology Reports Pub Date : 2023-03-14 DOI:10.1007/s11816-023-00824-x

Shivani Digra, Skarma Nonzom

{"title":"An insight into endophytic antimicrobial compounds: an updated analysis.","authors":"Shivani Digra, Skarma Nonzom","doi":"10.1007/s11816-023-00824-x","DOIUrl":null,"url":null,"abstract":"<p><p>Resistance in micro-organisms against antimicrobial compounds is an emerging phenomenon in the modern era as compared to the traditional world which brings new challenges to discover novel antimicrobial compounds from different available sources, such as, medicinal plants, various micro-organisms, like, bacteria, fungi, algae, actinomycetes, and endophytes. Endophytes reside inside the plants without exerting any harmful impact on the host plant along with providing ample of benefits. In addition, they are capable of producing diverse antimicrobial compounds similar to their host, allowing them to serve as useful micro-organism for a range of therapeutic purposes. In recent years, a large number of studies on the antimicrobial properties of endophytic fungi have been carried out globally. These antimicrobials have been used to treat various bacterial, fungal, and viral infections in humans. In this review, the potential of fungal endophytes to produce diverse antimicrobial compounds along with their various benefits to their host have been focused on. In addition, classification systems of endophytic fungi as well as the need for antimicrobial production with genetic involvement and some of the vital novel antimicrobial compounds of endophytic origin can further be utilized in the pharmaceutical industries for various formulations along with the role of nanoparticles as antimicrobial agents have been highlighted.</p>","PeriodicalId":20216,"journal":{"name":"Plant Biotechnology Reports","volume":null,"pages":null},"PeriodicalIF":1.7000,"publicationDate":"2023-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013304/pdf/","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Plant Biotechnology Reports","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1007/s11816-023-00824-x","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}

引用次数: 4

Abstract

Resistance in micro-organisms against antimicrobial compounds is an emerging phenomenon in the modern era as compared to the traditional world which brings new challenges to discover novel antimicrobial compounds from different available sources, such as, medicinal plants, various micro-organisms, like, bacteria, fungi, algae, actinomycetes, and endophytes. Endophytes reside inside the plants without exerting any harmful impact on the host plant along with providing ample of benefits. In addition, they are capable of producing diverse antimicrobial compounds similar to their host, allowing them to serve as useful micro-organism for a range of therapeutic purposes. In recent years, a large number of studies on the antimicrobial properties of endophytic fungi have been carried out globally. These antimicrobials have been used to treat various bacterial, fungal, and viral infections in humans. In this review, the potential of fungal endophytes to produce diverse antimicrobial compounds along with their various benefits to their host have been focused on. In addition, classification systems of endophytic fungi as well as the need for antimicrobial production with genetic involvement and some of the vital novel antimicrobial compounds of endophytic origin can further be utilized in the pharmaceutical industries for various formulations along with the role of nanoparticles as antimicrobial agents have been highlighted.

Abstract Image

查看原文本刊更多论文

深入了解内生抗菌化合物：最新分析。

与传统世界相比，微生物对抗菌化合物的耐药性是现代新出现的现象，这给从不同的可用来源发现新的抗菌化合物带来了新的挑战，例如药用植物、各种微生物，如细菌、真菌、藻类、放线菌和内生菌。内生植物存在于植物内部，不会对寄主植物产生任何有害影响，并提供充足的益处。此外，它们能够产生与宿主相似的多种抗菌化合物，使它们能够作为一系列治疗目的的有用微生物。近年来，全球范围内对内生真菌的抗菌特性进行了大量研究。这些抗菌药物已被用于治疗人类的各种细菌、真菌和病毒感染。在这篇综述中，真菌内生菌产生多种抗菌化合物的潜力及其对宿主的各种益处一直受到关注。此外，内生真菌的分类系统以及对具有基因参与的抗微生物生产的需求，以及一些重要的内生来源的新型抗微生物化合物可以进一步用于制药工业中的各种制剂，以及纳米颗粒作为抗微生物剂的作用已经得到了强调。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Plant Biotechnology Reports 生物-生物工程与应用微生物

CiteScore

4.10

自引率

4.20%

发文量

审稿时长

>12 weeks

期刊介绍： Plant Biotechnology Reports publishes original, peer-reviewed articles dealing with all aspects of fundamental and applied research in the field of plant biotechnology, which includes molecular biology, genetics, biochemistry, cell and tissue culture, production of secondary metabolites, metabolic engineering, genomics, proteomics, and metabolomics. Plant Biotechnology Reports emphasizes studies on plants indigenous to the Asia-Pacific region and studies related to commercialization of plant biotechnology. Plant Biotechnology Reports does not exclude studies on lower plants including algae and cyanobacteria if studies are carried out within the aspects described above.